Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FEN1 | P39748 | 2/20 | 0.50 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.49 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | RXRA | P19793 | 1/20 | 0.47 |
| ▸ | RXRB | P28702 | 1/20 | 0.47 |
| ▸ | RXRG | P48443 | 1/20 | 0.47 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.47 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 2/20 | 0.45 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.43 |
| ▸ | LPAR5 | Q9H1C0 | 3/20 | 0.43 |
| ▸ | TTR | P02766 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30856503 | 0.89 | FFAR4 (0.58) | FEN1CAMKK2FFAR4PTGS2RXRA | |
| SCHEMBL30856488 | 0.87 | SRD5A2 (0.59) | FEN1CAMKK2FFAR4PTGS2RXRA | |
| SCHEMBL25343498 | 0.86 | CYP2C8 (0.53) | FEN1CAMKK2FFAR4PTGS2RXRA | |
| SCHEMBL30519278 | 0.86 | CYP2C8 (0.53) | FEN1CAMKK2FFAR4PTGS2RXRA | |
| SCHEMBL21178076 | 0.86 | NCOA1 (0.58) | FEN1CAMKK2FFAR4PTGS2RXRA | |
| SCHEMBL4326298 | 0.85 | NCOA1 (0.62) | FEN1CAMKK2FFAR4PTGS2RXRA | |
| SCHEMBL1634704 | 0.81 | PARP15 (0.58) | RXRARXRBRXRGSRD5A2 | |
| SCHEMBL9422294 | 0.81 | SRD5A2 (0.61) | FEN1CAMKK2RXRARXRBRXRG | |
| SCHEMBL2710772 | 0.79 | SRD5A2 (0.59) | FEN1CAMKK2RXRARXRBRXRG | |
| SCHEMBL25908089 | 0.77 | PTGS2 (0.59) | CAMKK2FFAR4PTGS2NCOA1NCOA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11434322-B2 | Sulfobetaine group-comprising reactive compound, polymer thereof, and method of producing the polymer | NAGASE CHEMTEX CORPORATION (JP) | 2022-09-06 | — | — | US | disclosed |
| EP-3604275-B1 | SULFOBETAINE-GROUP-CONTAINING REACTIVE COMPOUND, POLYMER THEREOF, AND METHOD FOR PRODUCING POLYMER | NAGASE CHEMTEX CORP (JP) | 2022-02-16 | — | — | EP | disclosed |
| US-20200131300-A1 | SULFOBETAINE GROUP-CONTAINING REACTIVE COMPOUND, POLYMER THEREOF, AND METHOD FOR PRODUCING POLYMER | NAGASE CHEMTEX CORPORATION (JP) | 2020-04-30 | — | — | US | disclosed |
| EP-3604275-A1 | SULFOBETAINE-GROUP-CONTAINING REACTIVE COMPOUND, POLYMER THEREOF, AND METHOD FOR PRODUCING POLYMER | Nagase ChemteX Corporation (JP) | 2020-02-05 | — | — | EP | disclosed |
| EP-2058353-B1 | DIAMINE COMPOUND HAVING PHOSPHORYLCHOLINE GROUP, POLYMER THEREOF AND METHOD FOR PRODUCING THE SAME | UNIV TOKAI EDUCATIONAL SYSTEM (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-8063238-B2 | Diamine compound having phosphorylcholine group, polymer thereof, and process for producing the polymer | TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) | 2011-11-22 | — | — | US | disclosed |
| US-20100036081-A1 | Diamine Compound Having Phosphorylcholine Group, Polymer Thereof, and Process for Producing the Polymer | TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-2058353-A1 | DIAMINE COMPOUND HAVING PHOSPHORYLCHOLINE GROUP, POLYMER THEREOF AND METHOD FOR PRODUCING THE SAME | TOKAI UNIVERSITY EDUCATIONAL SYSTEM (JP) | 2009-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200131300-A1 | SULFOBETAINE GROUP-CONTAINING REACTIVE COMPOUND, POLYMER THEREOF, AND METHOD FOR PRODUCING POLYMER | CBR3, SCO2, MSRB3 | FEN1 1533/4885CAMKK2 4634/4885FFAR4 1635/4885 |
| US-20100036081-A1 | Diamine Compound Having Phosphorylcholine Group, Polymer Thereof, and Process for Producing the Polymer | PHOSPHO1, PCTP, PDAP1 | FEN1 3629/4885CAMKK2 3117/4885FFAR4 4247/4885 |
| US-11434322-B2 | Sulfobetaine group-comprising reactive compound, polymer thereof, and method of producing the polymer | CBR3, SCO2, MSRB3 | FEN1 1844/4885CAMKK2 4589/4885FFAR4 1609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.